Efficacy and safety profile of long‐term exposure to lenalidomide in patients with recurrent multiple myelomaGuillemette Fouquet, Xavier Leleu, Stéphanie Tardy et al.|Cancer|2013Cited by 31
Analysis of Clinical Arterial and Metabolic Parameters in Chronic Phase CML Patients On Nilotinib in a Single Center CohortHélène Labussière‐Wallet, Franck E. Nicolini, Fiorenza Barraco et al.|Blood|2012Cited by 10
Allogeneic hematopoietic stem cell transplant for hematological malignancies from mismatched 9/10 human leukocyte antigen unrelated donors: comparison with transplants from 10/10 unrelated donors and human leukocyte antigen identical siblingsMauricette Michallet, Franck E. Nicolini, Mohamad Sobh et al.|Leukemia & lymphoma/Leukemia and lymphoma|2014Cited by 9
Tacrolimus Extended Release Formulation Given As An Alternative To Ciclosporine A In Case Of Renal Impairment After Allogeneic HSCT: Results From a Prospective Pilot StudyMarie Y. Detrait, Fiorenza Barraco, Stéphane Morisset et al.|Blood|2013Cited by 0
Efficacy and Safety Profile of Long Term Exposure to Lenalidomide in Relapsed Multiple Myeloma.Guillemette Fouquet, Xavier Leleu, Stéphanie Tardy et al.|Blood|2012Cited by 0